Cargando…
A Double-Blind, Placebo-Controlled Study of Brexpiprazole in the Treatment of Borderline Personality Disorder
BACKGROUND: Borderline personality disorder (BPD) is associated with impaired quality of life and has a number of untoward public health associations. There is no established first-line pharmacological treatment for BPD, and available options are not suitable for all individuals. AIMS: To evaluate B...
Autores principales: | Grant, Jon E., Valle, Stephanie, Chesivoir, Eve, Ehsan, Dustin, Chamberlain, Samuel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612273/ https://www.ncbi.nlm.nih.gov/pubmed/35049469 http://dx.doi.org/10.1192/bjp.2021.159 |
Ejemplares similares
-
Tolcapone in Obsessive Compulsive disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial
por: Grant, Jon E., et al.
Publicado: (2021) -
Temperament in trichotillomania and skin picking disorder
por: Grant, Jon E., et al.
Publicado: (2023) -
Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study
por: Fleischhacker, W. Wolfgang, et al.
Publicado: (2016) -
Suicidal Ideation and Attempts in Trichotillomania
por: Grant, Jon E., et al.
Publicado: (2023) -
Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania
por: Vieta, Eduard, et al.
Publicado: (2021)